Altered hepatic mTORC1–TFEB/TFE3 signaling is associated with coordinated remodeling of bile acid metabolism during metabolic adaptation, underscoring a link between nutrient signaling and metabolic liver disease.
Abstract
The mechanistic target of rapamycin complex 1 (mTORC1) integrates nutrient and hormonal cues to regulate hepatic lipid metabolism with major implications for metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we show that altered hepatic mTORC1–TFEB/TFE3 signaling is associated with coordinated remodeling of bile acid (BA) metabolism during metabolic adaptation. Our data support a model in which cross-talk between mTORC1 and TFEB/TFE3 is associated with divergent regulation of bile acid synthesis and transformation. Depending on the mTORC1 signaling state, changes in hepatic Cyp2c70 and Cyp8b1 expression, together with altered cholesterol trafficking, were associated with shifts toward non–12-OH or 12-OH bile acid species. These effects were attenuated or reversed by Tfe3 deletion or rapamycin treatment. Furthermore, protein restriction (which inhibits mTORC1) similarly reshaped the BA profile in mice and correlated with improved metabolic outcomes in MASLD patients. Together, these findings uncover BA homeostasis as an integral component of the metabolic adaptations orchestrated by mTORC1, underscoring a link between nutrient signaling and metabolic liver disease.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Although gut microbiota dysbiosis and aberrant bile acid metabolism are central to MASLD pathogenesis, the critical keystone species and precise molecular mechanisms remain elusive. Here, we performed an...
Shao-Jun Li, W. Sheng, Yang Yang et al.· Microorganisms· 0 citations
The nutrient-sensing mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway controls cellular and organismal growth and metabolism, and aberrant activation is linked to human disease, including metabolic disease. Cellular studies have established regulatory mechanisms influencing mTORC1 activation, but th...
Krystle C. Kalafut, Y. Cormerais, Madi Y. Cissé et al.· Nature Communications· 1 citation
Interactions between microbiota and the host can profoundly affect human health. In particular, microbiota-derived metabolites influence liver physiology and contribute to the development of metabolic diseases, yet the molecular mechanisms underlying microbiome-host communication remain incompletely understood. Here, w...
Anna Pia Plazzo, Verena Filz, Michaela Prothiwa et al.· EMBO Molecular Medicine· 0 citations
The escalating global burden of metabolic diseases including obesity, type 2 diabetes, and metabolic dysfunction-associated fatty liver disease (MAFLD)-highlights an urgent need to identify new therapeutic targets. Although elevated hepatic de novo lipogenesis (DNL) is a hallmark of metabolic dysfunction, targeting i...
Wei Wang, Hui Wang, Yi-Han Liu et al.· Cell Death Discovery· 0 citations
BACKGROUND
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading global health burden, yet the regulatory nodes linking hepatic immune dysregulation to metabolic perturbations remain incompletely understood.
METHODS
We integrated bulk and single-cell RNA sequencing (scRNA-seq) to identify core...
Yan Wang, Shuang-Shuang Lu· Frontiers in Bioscience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.